https://orcid.org/0000-0002-4121-0448
Figures & data
Table 1 Primers Used for the Detection of aac(6ʹ)-lb, aac(3)-lla, rmtB, rmtC, armA, rmtD, blaNDM, blaVIM, and blaIMP Genes, and Expected Product Size
Table 2 Association Between Aminoglycoside Resistance and Carbapenem Resistance Genotypes in 19 Positive Aminoglycoside Resistance Genes in P. aeruginosa Clinical Isolates
Figure 1 The 173-bp PCR amplification of rmtB gene among P. aeruginosa isolates. First lane, DNA ladder, 100-bp DNA size marker; (1) P, positive control, from 2 to 20 clinical isolates; −ve, negative control.
Figure 2 The 315-bp PCR amplification of armA gene among P. aeruginosa isolates. (1) P, positive control; second lane, DNA ladder, 100-bp DNA size marker; (2) and (3), clinical isolates with positive results; −ve, negative control.
Figure 3 The 482-bp PCR amplification of aac(6ʹ)-lb gene among P. aeruginosa isolates. First lane, DNA ladder, 100-bp DNA size marker; (1) P, positive control; (2), (3), (4), and (5), clinical isolates; −ve, negative control.
Figure 4 The 700-bp PCR amplification of blaNDM gene among P. aeruginosa isolates. First lane, DNA ladder, 100-bp DNA size marker; −ve, negative control.
Figure 5 The 390-bp PCR amplification of blaVIM gene among P. aeruginosa isolates. First lane, DNA ladder, 100-bp DNA size marker; −ve, negative control.
